In Alvarez-Sanchez 2023 et al., on SLN mapping in canine MCT, what percentage of dogs had the same SLN identified by both ICTL and NIRF?
A. 40%
B. 55%
C. 65%
D. 80%
E. 95%
Answer: 80%
Explanation: ICLT and NIRF identified the same sentinel node in 80% of dogs, showing strong concordance when both methods were used together.
In Alvarez-Sanchez 2023 et al., on SLN mapping in canine MCT, which tumor type showed unexpectedly high rates of lymph node metastasis?
A. Visceral hemangiosarcoma
B. Cutaneous histiocytoma
C. Subcutaneous mast cell tumor
D. Squamous cell carcinoma
E. Soft tissue sarcoma
Answer: Subcutaneous mast cell tumor
Explanation: 7 of 8 dogs with subcutaneous MCT had metastatic nodes, challenging assumptions of benign behavior in this tumor subtype.
In Alvarez-Sanchez 2023 et al., on SLN mapping in canine MCT, which SLN detection method had the higher failure rate?
A. Near-infrared fluorescence (NIRF)
B. Indirect computed tomographic lymphography (ICTL)
C. Fine-needle aspiration cytology
D. Ultrasound-guided mapping
E. ALN biopsy alone
Answer: Near-infrared fluorescence (NIRF)
Explanation: NIRF failed in 20% of dogs, while ICTL failed in only 5%, making NIRF the less sensitive method individually.
In Alvarez-Sanchez 2023 et al., on SLN mapping in canine MCT, what was the histologic metastasis rate (HN2 or HN3) in excised lymph nodes?
A. 32%
B. 50%
C. 65.8%
D. 80%
E. 90%
Answer: 65.8%
Explanation: 27 of 41 excised lymph nodes were histologically metastatic, a high rate even though most tumors were low-to-intermediate grade.
In Alvarez-Sanchez 2023 et al., on SLN mapping in canine MCT, how often did the anatomic lymph node (ALN) match the SLN identified by ICTL?
A. 25%
B. 30%
C. 45%
D. 60%
E. 75%
Answer: 45%
Explanation: Only 45% of ALNs matched the ICTL-identified SLNs, indicating a high likelihood of misclassification when relying on anatomy alone.